Prefrontal sulcal prominence is inversely related to response to clozapine in schizophrenia
References (58)
- et al.
Behavioral and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat
Brain Res
(1980) - et al.
Serotonin receptors in the human brain. II. Characterization and autoradiographic localisation of 5-HT1C and 5-HT2 recognition sites
Brain Res
(1986) - et al.
Lesions of dopamine neurons in the medial prefrontal cortex: Effects on self-administration of amphetamine and dopamine synthesis in the brain of the rat
Neuropharmacology
(1987) Frontal lobe dysfunctions in schizophrenia. II: Impairments of psychological and brain functions
J Psychiatr Res
(1984)- et al.
Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics
Biol Psychiatry
(1986) - et al.
Neuroleptic withdrawal in chronic schizophrenia: CT and endocrine variables relating to psychopathology
Psychiatry Res
(1985) - et al.
Clinical correlates of sulcal widening in chronic schizophrenia
Psychiatry Res
(1983) - et al.
Amphetamine challenge test, response to treatment, and lateral ventricle size in schizophrenia
Biol Psychiatry
(1989) - et al.
Cortical modulation of striatal function
Brain Res
(1982) - et al.
Lateral ventricular enlargement and clinical response in schizophrenia
Psychiatry Res
(1985)
Midsaggital cortical pathomorphology of schizophrenia: A magnetic resonance imaging study
Psychiatry Res
Cortical atrophy in schizophrenia: Prevalence and associated features
Schizophr Res
Cluster Analysis for Applications
Drug therapy in schizophrenia—Variability of outcome and prediction of response
Can J Psychiatry
On methods and theory of reliability
J Nerv Ment Dis
Computed tomographic brain studies and treatment response in schizophrenia
Can J Psychiatry
Atrophy limited to the third ventricle in chronic schizophrenic patients
Arch Gen Psychiatry
Response to neuroleptic drugs as a device for classifying schizophrenia
Schizophr Bull
Clozapine: Neuroleptic-induced EPS and tardive dyskinesia
Psychopharmacology
The risks and benefits of clozapine versus chlorpromazine
J Clin Psychopharmacol
Problems in classification of schizophrenics as neuroleptic responders and nonresponders
J Nerv Ment Dis
A diagnostic interview: The schedule for affective disorders and schizophrenia
Arch Gen Psychiatry
Ex uno multi: Subtyping the schizophrenic syndrome
Biol Psychiatry
Computerised tomography in schizophrenia. Familial versus non-familial forms of illness
Br J Psychiatry
Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine
Arch Gen Psychiatry
Characteristics of very poor outcome schizophrenia
Am J Psychiatry
Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction
Br J Psychiatry
Dementia Praecox and Paraphrenia
Leponex-associated granulocytopenia: A review of the situation
Psychopharmacology
Cited by (80)
Quantitative biomarkers to predict response to clozapine treatment using resting EEG data
2020, Schizophrenia ResearchCitation Excerpt :It is worth noting that some of the selected features using the proposed feature selection algorithm were from the regions that are also identified in previous studies. Most of these studies showed measures of frontal area as a predictive value to clozapine treatment (Arango et al., 2003; Ertugrul et al., 2009; Friedman et al., 1991; Gross et al., 2004; Honer et al., 1995; Kang et al., 2001; Konicki et al., 2001; Molina et al., 2003; Rodriguez et al., 1997) (features 2–4, 6, and 7 in Table 2). Two more areas that are included in the selected features are temporal (features 1–3, 5) and parietal lobes (features 1), where their measures are shown to be linked to the prediction of clozapine treatment (Khodayari-Rostamabad et al., 2010; Lauriello et al., 1998; Molina et al., 2003).
Treatment-Resistant Schizophrenia
2016, Psychiatric Clinics of North AmericaBrain-imaging studies of treatment-resistant schizophrenia: A systematic review
2016, The Lancet PsychiatryNeuroimaging findings in treatment-resistant schizophrenia: A systematic review: Lack of neuroimaging correlates of treatment-resistant schizophrenia
2015, Schizophrenia ResearchCitation Excerpt :We are not aware of any studies examining structural changes following CLZ treatment in TRS, although several investigations have reported on baseline structural predictors of CLZ response. Friedman et al. (1991) found that CLZ response was positively related to a smaller prefrontal sulcal prominence at baseline, reflecting prefrontal atrophy, in those with TRS (Friedman et al., 1991). Konicki et al. (2001) reported that CLZ responders with TRS had less prefrontal sulcal widening at baseline than nonresponders (Konicki et al., 2001).
Nonresponse to clozapine and premorbid functioning in treatment refractory schizophrenia
2010, Comprehensive Psychiatry